Sharps Technology Completes Acquisition Of Safegard Medical Syringe Manufacturing Facility
Acquiring Company
SkyAI, Inc.
Acquired Company
Safegard Medical Syringe Manufacturing Facility
MelvilleManufacturingInformation TechnologyCommunity And LifestyleHealth CareMedicalmedical devicesDescription
Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class, single use smart safety syringe products, is pleased to announce the Company completed its acquisition of Safegard Medical’s syringe manufacturing facility in Hungary.
Quick answer
SkyAI, Inc. is acquiring Safegard Medical Syringe Manufacturing Facility, announced July 15, 2022. SkyAI, Inc. is based in Melville, New York, United States.
- How much did SkyAI, Inc. pay for Safegard Medical Syringe Manufacturing Facility?
- The deal value was not disclosed.
- What does SkyAI, Inc. do?
- Sharps Technology, Inc. is a medical device company addressing global issues while engineering a safer future for healthcare providers and people everywhere through innovation.
- Where are SkyAI, Inc. and Safegard Medical Syringe Manufacturing Facility based?
- SkyAI, Inc. is based in Melville, New York, United States.
- Who are the decision-makers at SkyAI, Inc?
- Fundz holds 2 contacts at SkyAI, Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Community And Lifestyle and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Bristol Myers Squibb And Turning Point Therapeutics Announce Expiration Of Hsr Act Waiting Period And Clearance From Federal Cartel Office Of Germany Related To Pending Acquisition Of Turning Point Therapeutics (August 16, 2022)
- Bristol Myers Squibb Completes Acquisition Of Turning Point Therapeutics, Expanding Precision Oncology Portfolio (August 17, 2022)
- Conmed Completes Acquisition Of Biorez, Inc. (August 9, 2022)
- Conmed Announces Definitive Agreement To Acquire Biorez, Inc. (August 1, 2022)
- Archimed Completes Acquisition Of Natus Medical Incorporated For $1.2 Billion Total Equity Value, $1.2B (July 21, 2022)
- Canon Medical Systems Usa Inc. Announces Expansion Of Distributorship With The Acquisition Of Nxc Imaging (July 11, 2022)
Who to call at SkyAI, Inc., and when
When SkyAI, Inc. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day SkyAI, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SkyAI, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SkyAI, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SkyAI, Inc. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Safegard Medical Syringe Manufacturing Facility?
Safegard Medical Syringe Manufacturing Facility was acquired by SkyAI, Inc., based in Melville. The deal was reported on July 15, 2022. Sharps Technology, Inc. is a medical device company addressing global issues while engineering a safer future for healthcare providers and people everywhere through innovation. SkyAI, Inc. is publicly traded (SKYA) and operates in Manufacturing.
When did SkyAI, Inc. acquire Safegard Medical Syringe Manufacturing Facility?
SkyAI, Inc.'s acquisition of Safegard Medical Syringe Manufacturing Facility was reported on July 15, 2022. Sharps Technology, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Safegard Medical Syringe Manufacturing Facility do?
Safegard Medical Syringe Manufacturing Facility is the company acquired in this transaction. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.